Carlos Correa is on the verge of losing out on his second $300 million deal in just under a week. The San Francisco Giants and now New York Mets are balking at his medicals. Who’s got next?
Carlos Correa entered his second straight offseason with the expectation that he would receive a $300 million contract. When healthy — which he is most of the time — Correa is a top-5 shortstop in all of baseball, and an argument can be made that he is one of the best all-around players in the game.
So, what’s the holdup then?
It’s Correa’s physical which is keeping him from finding a new team. While many have pointed to Correa’s back in the past as an issue that could keep him from a long-term commitment, in this case it’s surprisingly an old ankle injury he suffered while in the minor leagues.
Correa underwent surgery on his leg long ago, but there is some concern as to his longevity at the shortstop position. With that in mind, it makes sense that a 10-plus year commitment would scare some franchises off.
Perhaps a restructured contract could avoid all the commotion, but for Scott Boras, that would be admitting defeat. So if the Mets and Steve Cohen fall through, what other teams would take a swing at the 28-year-old?
Minnesota Twins should try again on Carlos Correa
The Twins offered Correa and Boras a 10-year, $285 million contract before he turned them down to sign with the Giants. If they offered that same contract — barring any issues with the physical, of course — odds are Correa’s team would take it.
This is all assuming the Mets deal with Correa falls through, of course. Boras reportedly gave Minnesota a chance to bring back Correa after the Giants ordeal, but the Twins failed to meet the asking price once again.
At a lower price tag, and perhaps a shorter term by the time this is all said and done, Correa back in Minneapolis might make more sense.